{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:46:44Z","timestamp":1791269204610,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,15]]},"DOI":"10.1097\/01.tp.0000438197.38413.f2","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T12:03:59Z","timestamp":1389096239000},"page":"569-575","source":"Crossref","is-referenced-by-count":30,"title":["Risk Factors for Late-Onset Cytomegalovirus Infection or Disease in Kidney Transplant Recipients"],"prefix":"10.1097","volume":"97","author":[{"given":"Alainna J.","family":"Jamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusegun","family":"Famure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Joseph","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210129","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1681\/ASN.V124848","article-title":"Cytomegalovirus in renal transplantation.","volume":"12","author":"Brennan","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R2-15-20210129","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QCO.0b013e328285a358","article-title":"The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the silo hypothesis.","volume":"20","author":"Rubin","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"R3-15-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM198302103080603","article-title":"Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation.","volume":"308","author":"Schooley","year":"1983","journal-title":"N Engl J Med"},{"key":"R4-15-20210129","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9343(97)80021-6","article-title":"The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients.","volume":"103","author":"George","year":"1997","journal-title":"Am J Med"},{"key":"R5-15-20210129","first-page":"539","article-title":"Infections and solid organ transplant rejection: a cause-and-effect relationship Lancet Infect D","volume":"2","author":"Cainelli","year":"2004","journal-title":"is"},{"key":"R6-15-20210129","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1097\/00007890-199912270-00011","article-title":"Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients.","volume":"68","author":"Humar","year":"1999","journal-title":"Transplantation"},{"key":"R7-15-20210129","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1681\/ASN.V7112476","article-title":"Peripheral T cell activation in long-term renal transplant patients: concordant upregulation of adhesion molecules and cytokine gene transcription.","volume":"11","author":"Kern","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"R8-15-20210129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.ajkd.2011.04.010","article-title":"Human cytomegalovirus and kidney transplantation: a clinicians update.","volume":"58","author":"De Keyzer","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R9-15-20210129","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/01.tp.0000204048.90367.97","article-title":"24-Week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course.","volume":"81","author":"Doyle","year":"2006","journal-title":"Transplantation"},{"key":"R10-15-20210129","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1600-6143.2007.02133.x","article-title":"Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial.","volume":"8","author":"Kliem","year":"2008","journal-title":"Am J Transplant"},{"key":"R11-15-20210129","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/528718","article-title":"Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation.","volume":"46","author":"Arthurs","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R12-15-20210129","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1111\/j.1600-6143.2009.02897.x","article-title":"AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplant recipients.","volume":"9","author":"Humar","year":"2009","journal-title":"Am J Transplant"},{"key":"R13-15-20210129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"R14-15-20210129","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients.","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"R15-15-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1399-3062.2004.00043.x","article-title":"Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.","volume":"6","author":"Murray","year":"2004","journal-title":"Transpl Infect Dis"},{"key":"R16-15-20210129","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days of valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients.","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"key":"R17-15-20210129","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(00)02607-6","article-title":"Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid organ transplants.","volume":"356","author":"Limaye","year":"2000","journal-title":"Lancet"},{"key":"R18-15-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ajhp\/62.suppl_1.S7","article-title":"Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients.","volume":"62","author":"Razonable","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"R19-15-20210129","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","article-title":"Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients.","volume":"6","author":"Khoury","year":"2006","journal-title":"Am J Transplant"},{"key":"R20-15-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.tp.0000190424.30178.43","article-title":"Primary cytomegalovirus disease after five years of antiviral prophylaxis.","volume":"81","author":"Kijpittayarit","year":"2006","journal-title":"Transplantation"},{"key":"R21-15-20210129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1399-3062.2011.00624.x","article-title":"Risk factors for late-onset cytomegalovirus disease in donor seropositiverecipient seronegative kidney transplant recipients who receive antiviral prophylaxis.","volume":"13","author":"Boudreault","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"R22-15-20210129","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1111\/j.1600-6143.2011.03611.x","article-title":"Impact of cytomegalovirus disease in DR kidney transplant patients receiving 6 months low-dose valganciclovir prophylaxis.","volume":"11","author":"Luan","year":"2011","journal-title":"Am J Transplant"},{"key":"R23-15-20210129","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1399-3062.2010.00532.x","article-title":"Choice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipient-negative kidney transplant recipients.","volume":"12","author":"Luan","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"R24-15-20210129","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1111\/j.1600-6143.2010.03225.x","article-title":"Primary CMV infections are common in kidney transplant recipients after 6 months valganciclovir prophylaxis.","volume":"10","author":"Helantera","year":"2010","journal-title":"Am J Transplant"},{"key":"R25-15-20210129","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/01.TP.0000142619.01510.A5","article-title":"Risk factors for cytomegalovirus viremia and disease developing after prophylaxis cessation in high-risk solid-organ transplant recipients.","volume":"78","author":"Freeman","year":"2004","journal-title":"Transplantation"},{"key":"R26-15-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ki.1993.234","article-title":"Infections disease complications of renal transplantation.","volume":"44","author":"Rubin","year":"1993","journal-title":"Kidney Int"},{"key":"R27-15-20210129","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1681\/ASN.V391541","article-title":"Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review.","volume":"3","author":"Vanholder","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"R28-15-20210129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1525-139X.2006.00175.x","article-title":"Neutrophil dysfunction and infection risk in end-stage renal disease.","volume":"19","author":"Chonchol","year":"2006","journal-title":"Semin Dial"},{"key":"R29-15-20210129","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1046\/j.1523-1755.2001.59780206.x","article-title":"Molecular aspects of T- and B-cell function in uremia.","volume":"78","author":"Girndt","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"R30-15-20210129","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0891-5520(05)70174-4","article-title":"Immunologic defects and vaccination in patients with chronic renal failure.","volume":"15","author":"Pesanti","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"R31-15-20210129","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/j.ajkd.2005.08.032","article-title":"The use of vaccines in adult patients with renal disease.","volume":"46","author":"Dinits-Pensy","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R32-15-20210129","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1097\/01.ASN.0000074237.78764.D1","article-title":"Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study.","volume":"14","author":"Allon","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R33-15-20210129","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ndt\/gfh729","article-title":"The spectrum of infection-related morbidity in hospitalized haemodialysis patients.","volume":"20","author":"Allon","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R34-15-20210129","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1053\/j.ajkd.2010.04.016","article-title":"Infection-related hospitalizations in older patients with ESRD.","volume":"56","author":"Dalrymple","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R35-15-20210129","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation.","volume":"6","author":"Humar","year":"2006","journal-title":"Am J Transplant"},{"key":"R36-15-20210129","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff 09 Meeting Report: Antibody mediated graft deterioration and implementation of Banff Working Groups.","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"},{"key":"R37-15-20210129","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1523-1755.2005.00602.x","article-title":"BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients.","volume":"68","author":"Vasudev","year":"2005","journal-title":"Kidney Int"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.tp.0000438197.38413.f2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:24:09Z","timestamp":1647890649000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201403150-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,15]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000438197.38413.f2","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3,15]]}}}